Patents Assigned to HemaSure Inc.
-
Publication number: 20030062299Abstract: A high capacity leukocyte depletion filtration media incorporates a high specific surface area components with a matrix of fibers, yielding a filtration medium that removes leukocytes by at least 99.99%. The filtration medium uses a significantly low weight ratio of high specific surface area components to the matrix of fibers. The high specific area creates a multitude of adhesion sites for leukocytes while the low weight ratios allow good filtration flow rates. The filtration medium is incorporated into a filter device for removing leukocytes from biological fluids.Type: ApplicationFiled: October 23, 2002Publication date: April 3, 2003Applicant: Whatman Hemasure, Inc.Inventors: Eric K. Lee, Paul J. Vernucci, Samuel C. Williams
-
Publication number: 20030057147Abstract: A filtration system for the filtration of a biological fluid includes a filtration device interposed between a fluid supply source and a collection container. The filtration device includes a filtration assembly disposed within a housing. The housing has an inlet for receiving unfiltered fluid from the supply source and an outlet for exiting filtered fluid to the collection container. The filtration assembly includes a central core projecting into the housing and surrounded by filter material. The housing may be collapsible around the filter material to aid in the flow of the fluid and minimize hold-up fluid upstream of the filtration device.Type: ApplicationFiled: September 24, 2001Publication date: March 27, 2003Applicant: Hemasure, Inc.Inventor: Peter C. Sutcliffe
-
Patent number: 6495039Abstract: An in-line biological liquid filtration system and method comprises a collection container for receiving biological liquid. A filter is located downstream of the collection container and in fluid flow communication therewith. A storage container for receiving filtered biological liquid is located downstream of the filter and the storage container is in fluid flow communication with the filter and with the collection container. An additive solution is located in the storage container. At least one automatic control member automatically restricts a flow of biological liquid or additive solution when flowing the liquid or solution between the collection container and the storage container.Type: GrantFiled: June 27, 2000Date of Patent: December 17, 2002Assignee: Whatman Hemasure, Inc.Inventors: Eric K. Lee, Franco Castino
-
Patent number: 6428712Abstract: A filtration system and method for the filtration of a biological liquid are disclosed. The system and method may include a biological liquid collection assembly, a filtration assembly in communication with the collection assembly and a blood components preservative assembly in communication with the collection assembly. The preservative assembly includes a blood components preservative container and the preservative container may contain a blood components preservative solution and contains a measured quantity of a sterile gas. The preservative assembly is adapted to automatically transfer at least a portion of, respectively, the preservative solution, if present, and the gas to the collection assembly under a force of gravity once fluid flow communication is commenced between the preservative container and the collection assembly.Type: GrantFiled: April 6, 2000Date of Patent: August 6, 2002Assignee: Hemasure, Inc.Inventor: Franco Castino
-
Publication number: 20020053548Abstract: A high capacity leukocyte depletion filtration media incorporates a high specific surface area components with a matrix of fibers, yielding a filtration medium that removes leukocytes by at least 99.99%. The filtration medium uses a significantly low weight ratio of high specific surface area components to the matrix of fibers. The high specific area creates a multitude of adhesion sites for leukocytes while the low weight ratios allow good filtration flow rates. The filtration medium is incorporated into a filter device for removing leukocytes from biological fluids.Type: ApplicationFiled: November 27, 2001Publication date: May 9, 2002Applicant: Whatman Hemasure Inc.Inventors: Eric K. Lee, Paul J. Vernucci, Samuel C. Williams
-
Patent number: 6369394Abstract: An apparatus and method for illuminating a fluid having photosensitive material therein comprising a surface and a roller separated from the surface by a space. The space is adapted to receive a flexible container therein. The flexible container on the surface contacts the roller and the surface for translation through the space. A light source is adapted to transmit light to the space to illuminate the fluid and react with the photosensitive material as the flexible container translates through the space.Type: GrantFiled: February 26, 1999Date of Patent: April 9, 2002Assignee: Whatman Hemasure, Inc.Inventor: Eric K. Lee
-
Patent number: 6337026Abstract: A high capacity leukocyte depletion filtration media incorporates a high specific surface area components with a matrix of fibers, yielding a filtration medium that removes leukocytes by at least 99.99%. The filtration medium uses a significantly low weight ratio of high specific surface area components to the matrix of fibers. The high specific area creates a multitude of adhesion sites for leukocytes while the low weight ratios allow good filtration flow rates. The filtration medium is incorporated into a filter device for removing leukocytes from biological fluids.Type: GrantFiled: March 8, 1999Date of Patent: January 8, 2002Assignee: Whatman Hemasure, Inc.Inventors: Eric K. Lee, Paul J. Vernucci, Samuel C. Williams
-
Patent number: 6274055Abstract: An in-line liquid filtration device useable for filtration of blood, blood products or the like includes a housing having an inlet port, an outlet port, at least one filter element disposed in the housing between the inlet port and outlet port so as to filter liquid which flows into the filtration device via the inlet port. The filter element divides the housing into a first chamber and a second chamber. The device allows gases to vent the filtration device through the outlet port. The means may include a flow deflector within the first chamber and/or the second chamber. The means may also include a channel, preferably spiral, within either the first chamber and/or second chamber. The filtration device allows air therein to be purged downstream into either an air collecting bag or into the blood receiving bag without the manipulation of the height of the filtration device or the blood receiving bag.Type: GrantFiled: December 20, 1999Date of Patent: August 14, 2001Assignee: Hemasure, Inc.Inventor: Peter Zuk, Jr.
-
Patent number: 6251292Abstract: An in-line gravity filtration device for biological fluids such as blood or blood products is disclosed. The device includes a series of channels formed downstream of filtration elements. The channels are defined in cross sectional area by the distance between the filtration elements and their bottoms. The channels are configured to form flow paths to an outlet port so that air within the channels is forced downstream through the outlet port thereby minimizing air being trapped on the downstream side of the device. For optimum performance, the cross section area of a single continuous channel, or the sum of the cross sectional area of parallel channels, leading to a single outlet port, should not exceed the cross sectional area of the outlet port.Type: GrantFiled: November 4, 1999Date of Patent: June 26, 2001Assignee: Hemasure, Inc.Inventor: Peter Zuk, Jr.
-
Patent number: 6177019Abstract: A method for removing tumor cells from tumor cell-contaminated stem cell products is disclosed. One embodiment of the method relies on an in-line filtration device that includes a tumor cell reduction filter means, preferably comprised of one or more tumor cell reduction filter pads. The tumor cell reduction filter means provides at least a ten-fold reduction in tumor cells while allowing for at least a 30% recovery of stem cells in a filtered stem cell product.Type: GrantFiled: February 24, 1999Date of Patent: January 23, 2001Assignee: HemaSure Inc.Inventors: Franco Castino, Sumith R. Wickramasinghe
-
Patent number: 6159375Abstract: Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.Type: GrantFiled: August 9, 1999Date of Patent: December 12, 2000Assignee: Hemasure, Inc.Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp
-
Patent number: 6123859Abstract: An in-line biological liquid filtration system and method comprises a collection container for receiving biological liquid. A filter is located downstream of the collection container and in fluid flow communication therewith. A storage container for receiving filtered biological liquid is located downstream of the filter and the storage container is in fluid flow communication with the filter and with the collection container. An additive solution is located in the storage container. At least one automatic control member automatically restricts a flow of biological liquid or additive solution when flowing the liquid or solution between the collection container and the storage container.Type: GrantFiled: April 22, 1999Date of Patent: September 26, 2000Assignee: HemaSure Inc.Inventors: Eric K. Lee, Franco Castino
-
Patent number: 6030539Abstract: An in-line liquid filtration device useable for filtration of blood, blood products or the like includes a housing having an inlet port, an outlet port, at least one filter element disposed in the housing between the inlet port and outlet port so as to filter liquid which flows into the filtration device via the inlet port. The filter element divides the housing into a first chamber and a second chamber. The device allows gases to vent the filtration device through the outlet port. The means may include a flow deflector within the first chamber and/or the second chamber. The means may also include a channel, preferably spiral, within either the first chamber and/or second chamber. The filtration device allows air therein to be purged downstream into either an air collecting bag or into the blood receiving bag without the manipulation of the height of the filtration device or the blood receiving bag.Type: GrantFiled: November 19, 1997Date of Patent: February 29, 2000Assignee: HemaSure, Inc.Inventor: Peter Zuk, Jr.
-
Patent number: 6015500Abstract: A liquid filtration device useable for removing leukocytes from blood contains a first chamber which is in fluid flow relationship with a second chamber. Filtration elements separate the first chamber from the second chamber so that liquid flowing from the first chamber is filtered thereby prior to entry into the second chamber. A passage leads from the second chamber into the first chamber and a hydrophobic filter may be used to prevent liquid from the first chamber from flowing through the passage into the second chamber while allowing air to flow therethrough. An outlet is located in the second chamber, preferably at the bottom thereof. A second outlet may be located within the second chamber and may be placed in fluid flow relationship therewith by a conduit or the like.Type: GrantFiled: July 20, 1998Date of Patent: January 18, 2000Assignee: Hemasure Inc.Inventor: Peter Zuk, Jr.
-
Patent number: 6010633Abstract: An in-line gravity filtration device for biological fluids such as blood or blood products is disclosed. The device includes a series of channels formed downstream of filtration elements. The channels are defined in cross sectional area by the distance between the filtration elements and their bottoms. The channels are configured to form flow paths to an outlet port so that air within the channels is forced downstream through the outlet port thereby minimizing air being trapped on the downstream side of the device. For optimum performance, the cross section area of a single continuous channel, or the sum of the cross sectional area of parallel channels, leading to a single outlet port, should not exceed the cross sectional area of the outlet port.Type: GrantFiled: March 6, 1997Date of Patent: January 4, 2000Assignee: Hemasure Inc.Inventors: Peter Zuk, Jr., Jonathan C. Alt
-
Patent number: 5938940Abstract: An in-line liquid filtration device useable for filtration of blood, blood products or the like includes a housing having an inlet port, an outlet port, at least one filter element disposed in the housing between the inlet port and outlet port so as to filter liquid which flows into the filtration device via the inlet port. The filter element divides the housing into a first chamber and a second chamber. The device allows gases to vent the filtration device through the outlet port. The means may include a flow deflector within the first chamber and/or the second chamber. The means may also include a channel, preferably spiral, within either the first chamber and/or second chamber. The filtration device allows air therein to be purged downstream into either an air collecting bag or into the blood receiving bag without the manipulation of the height of the filtration device or the blood receiving bag.Type: GrantFiled: June 10, 1998Date of Patent: August 17, 1999Assignee: HemaSure Inc.Inventor: Peter Zuk, Jr.
-
Patent number: 5935436Abstract: Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.Type: GrantFiled: May 23, 1997Date of Patent: August 10, 1999Assignee: Hemasure Inc.Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp
-
Patent number: 5902490Abstract: The filtration method involves processing biological liquid from an enclosed flexible supply bag to a filtration media within a processing system wherein the flow of biological liquid within the system is restricted to allow the biological liquid to back up above the level of a port located upstream within the system and preventing gas from entering into the processing system through the port by maintaining the level of biological liquid above the port until the flow of biological liquid from the flexible supply bag ceases. The system automatically allows gas to enter into the system through the port when the flow of biological liquid ceases thereby draining the biological liquid into a receiving bag. The flow may be restricted by a narrow cross-sectional area within the processing system and the port may be covered by a hydrophobic filter media.Type: GrantFiled: July 16, 1996Date of Patent: May 11, 1999Assignee: HemaSure, Inc.Inventor: Peter Zuk, Jr.
-
Patent number: 5846427Abstract: Improved devices for blood separations are provided based on the use of hollow fiber membrane arrays in extra-lumenal crossflow filtration. Blood is processed extra-lumenally across an ordered array of microporous hollow fibers to separate cells from plasma. By use of extra-lumenal crossflow filtration with suitably oriented fibers, the separation device is more efficient than existing devices which benefits a patient or donor by reducing extracorporeal volume.Type: GrantFiled: October 23, 1996Date of Patent: December 8, 1998Assignee: HemaSure, Inc.Inventors: Stephen B. Kessler, Sumith Ranil Wickramasinghe
-
Patent number: 5817237Abstract: Filter devices for simultaneously removing leukocytes and viral inactivating agents from whole blood or blood fractions are disclosed. One type of device comprises (1) a housing surrounding (2) activated carbon and (3) a mechanically stable polymeric material which may optionally be modified to attach a ligand for leukocytes. General methods for removing leukocytes and viral inactivating agents from blood and plasma are also disclosed.Type: GrantFiled: June 4, 1997Date of Patent: October 6, 1998Assignee: Hemasure, Inc.Inventors: Eric Kin-Lam Lee, Yves Fouron, Franco Castino, Charles Melvyn Zepp